ValiRx plc (LON:VAL – Get Free Report) traded down 9.5% during trading on Thursday . The stock traded as low as GBX 0.40 ($0.01) and last traded at GBX 0.43 ($0.01). 1,353,628 shares traded hands during trading, a decline of 82% from the average session volume of 7,439,741 shares. The stock had previously closed at GBX 0.48 ($0.01).
ValiRx Price Performance
The company has a market cap of £1.55 million, a PE ratio of -0.28 and a beta of 0.59. The company has a debt-to-equity ratio of 0.44, a current ratio of 6.65 and a quick ratio of 1.27. The stock’s 50-day moving average is GBX 0.64 and its 200 day moving average is GBX 1.05.
About ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Stories
- Five stocks we like better than ValiRx
- Stock Market Sectors: What Are They and How Many Are There?
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- Best Stocks Under $5.00
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
